MDMA may soon join the psychedelic drug resurgence—not for partying, but for tackling severe mental trauma, such as post-traumatic stress disorder.| Singularity Hub
This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in patients with major depressive disorder compared with placebo.| jamanetwork.com